3 Penny Stocks to Add to Your April Watchlist
If you’re thinking of investing in penny stocks, there’s no better time than the present. In the past week or so, we’ve seen both blue chips and penny stocks begin to rise. This comes after several weeks of mostly bearish trading patterns.
But as always, before you invest, it’s important to do your research. For that reason, it is crucial to always know which stocks are worth investing in, and make sure you understand the risks involved. This is especially true when it comes to penny stocks as they tend to be some of the most volatile stocks out there. That is the result of the under $5 price tag and the amount at which they are impacted by speculation.
[Read More] 3 Trending Penny Stocks to Watch in April 2022
The stock market is always changing, so it’s important to stay up-to-date on the latest news and changes in the market. By doing so, you’ll be able to make better investment decisions and hopefully see a higher return on your investment. As stated earlier, with penny stocks, the rate of speculation is extremely high. And right now, the largest impacting factors on the stock market are the war in Ukraine, rising interest rates and inflation in the U.S., and recent movement with meme stocks and cryptocurrency.
Despite these factors, penny stocks still can be a great way to make money. Just be sure to do your homework and understand the risks before you invest. Considering this, let’s take a look at three penny stocks that could be worth watching next week.
3 Penny Stocks to Watch in April 2022
- Jaguar Health Inc. (NASDAQ: JAGX)
- Bitnile Holdings Inc. (NYSE: NILE)
- Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)
Jaguar Health Inc. (NASDAQ: JAGX)
One of the biggest recent gainers we’ve seen is Jaguar Health Inc. On March 31st, shares of JAGX stock managed to climb by more than 31%. This is a major gain that reflects over a month of bullishness for Jaguar Health. And over the last four weeks, shares of JAGX stock have shot up by more than 50%. The biggest recent news from Jaguar Health came on March 31st when the company announced that it had entered into an exclusive Crofelemer distribution and agreement license with Quadrio Pharmaceuticals. The goal is to begin reaching Middle Eastern markets with this product.
“Our collaboration with Quadri Pharma is a welcome and important step towards making crofelemer’s novel mechanism of action available to patients in need in global markets. We look forward to a close relationship with Quadri Pharma and their team of experienced professionals.”The Executive Vice President of Corporate and Business Development at Jaguar, Karen Brunke, PhD.
Agreements like this are crucial when it comes to biotech penny stocks. And as we see, the speculative effect is quite large. While this is not a be all end all deal for JAGX stock, it’s clear that it will have a large and long term effect moving forward. Considering this, will JAGX be on your list of penny stocks to buy or not?
Bitnile Holdings Inc. (NYSE: NILE)
Bitnile Holdings is a penny stock that has become extremely popular over the past few weeks. The most recent news from BitNile came on March 28th, when it announced the payment in full of its senior secured notes. These senior secure notes were worth $66 million, hence why this is such a big deal.
“We are pleased to be in a position to fully pay our senior secured debt this week. Other than the loans on our portfolio of hotels, which are non-recourse to the parent company, the Company will be virtually debt free.”The CFO of BitNile, Kenneth S. Cragun
Having the reduction of debt here is a major positive for the company and investors alike. So considering that will make it easier to understand whether NILE stock is worth watching or not.
If you’re not familiar, BitNile, is a holding company that acquires undervalued business and disruptive technology. This includes Bitcoin mining as well as products for industries such as defense, aerospace, textiles and much more. With all of this in mind, do you think that NILE stock is worth adding to your penny stocks watchlist?
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)
Another big gainer on March 31st was Tonix Pharmaceuticals. By EOD, shares of TNXP stock had shot up by over 3.8%. And in the past month, shares of TNXP stock have shot up by more than 21%. The big news recently from the company came on March 31st, when it announced that its TNX-1500 product will enter Phase 1 clinical trials. Aside from this, on March 21st, the company announced that its fibromyalgia candidate did not achieve statistical significance.
“We believe the difference between these study results may be largely driven by a 79% increase in adverse event-related participant discontinuations in the drug treatment group in RALLY compared to RELIEF. Similarly, a 77% increase of adverse event-related participant discontinuations was observed in the placebo group in RALLY compared to RELIEF.”The CMO of Tonix Pharmaceuticals, Gregory Sullivan
While this is slightly disheartening, it is the reality of the biotech industry. With that in mind, do you think TNXP stock is worth buying or not?
Can Penny Stocks Be a Good Investment?
Investing in penny stocks can be tricky. With so much going on in the stock market and so much impacting prices, it is difficult to keep up with the constant price moves.
Regardless, understanding the latest news and events that are going on, will give you the greatest chance of profitability. Considering all of this, do you think that penny stocks are a good investment this month or not?